A return trip to the WNBA Finals is within reach for the New York Liberty when they hit the road Friday to face the Las Vegas Aces, who are trying to stave off the end to their two-year championship ...

San Diego right-hander Joe Musgrove departed the Padres’ National League wild-card series game against the visiting Atlanta ...

The Milwaukee Brewers will turn to midseason acquisition Frankie Montas to stave off yet another postseason meltdown when they face the New York Mets on Wednesday in the second game of a National ...

September witnessed a robust recovery in global equity fund inflows, signaling renewed investor confidence in global markets, according to HSBC. This resurgence in fund inflows highlights a shift in ...

Redshirt freshman Brock Glenn will start at quarterback on Saturday for Florida State against No. 15 Clemson as starter DJ Uiagalelei deals with a right hand injury, ESPN reported Monday. Per the ...

Hall of Famer Dikembe Mutombo died Monday from brain cancer, the NBA announced. He was 58. Known for both his shot-blocking and finger-wagging in addition to a pronounced gravelly voice, Mutombo ...

Baker Mayfield’s sizzling performance carried the Tampa Bay Buccaneers to a 33-16 victory against the Philadelphia Eagles on ...

Wil Lutz kicked a go-ahead 47-yard field goal with 8:55 left to lift the Denver Broncos to a 10-9 win over the New York Jets ...

Jasmine Suwannapura of Thailand overcame a historic round from Lucy Li, sinking an eagle putt on the second playoff hole to emerge with a victory Sunday at the Walmart NW Arkansas Championship in ...

Tony Medley is an attorney, columnist, and MPAA-accredited film critic. His reviews are published in The Larchmont Chronicle, Telicom Magazines, The Tolucan Times, CWEB.com, robinhoodnews.com, ...

Tom Kim apologized to U.S. captain Jim Furyk and Xander Schauffele on Sunday, one day after his public comments caused a bit of a stir at the 2024 Presidents Cup. On Saturday, Kim told reporters that ...

Indaptus Therapeutics, Inc. (NASDAQ:INDP) is in a critical phase with its leading candidate, Decoy20, undergoing Phase I clinical trials, marking a significant step towards commercial viability. The ...